Mammoth Biosciences
Mammoth Biosciences is a biotechnology firm that harnesses proprietary ultracompact CRISPR systems to develop curative gene‑editing therapies and precision diag
Company facts
- Founded
- 2017
- Employees
- 200
- Headquarters
- United States
- Type
- Startup
About
Mammoth Biosciences is a biotechnology firm that harnesses proprietary ultracompact CRISPR systems to develop curative gene‑editing therapies and precision diagnostics. Founded by CRISPR pioneer Jennifer Doudna and colleagues, the company focuses on in‑vivo editing of hard‑to‑reach tissues using nuclease, base‑editing, gene‑writing, and epigenetic modalities. Its pipeline includes a range of therapeutic candidates, and it partners with leading pharma and biotech companies to extend the reach of its technology. With deep scientific expertise and a robust IP portfolio, Mammoth is positioned to transform patient care through advanced CRISPR solutions.